Table 1.

Distribution of K. pneumoniae bla_KPC-2 and bla_KPC-3 isolates and resistance to meropenem.

blaKPC allele	KpnCluster	MLST	The Netherlands			Caribbean			Total
		Sequence type	S	I	R	S	I	R
blaKPC-2	KpnCluster-003	ST258			2				2
	KpnCluster-005	ST258			3				3
	KpnCluster-019	ST560	1	2		6	4		13
	KpnCluster-021	ST144					1	2	3
	KpnCluster-041	ST560				2			2
	Non-KpnCluster	variant	3	4	14	1	2	4	28
	Subtotal								51
blaKPC-3	KpnCluster-008	ST512			4				4
	KpnCluster-025	ST307		1	6				7
	KpnCluster-038	ST11			2				2
	KpnCluster-050	ST13	1		1				2
	Non-KpnCluster	variant	3	5	8	1		1	18
	Subtotal								33
	Total		8	12	40	10	7	7	84

Based on the clinical breakpoints according to EUCAST, the isolates were classified as sensitive (S; < 2 mg/L), intermediate (I; ≥ 2 to 8 mg/L) and resistant (R; > 8 mg/L).